(Q38186638)

English

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature

scientific article published on 08 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 August 2017

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature (English)

1 reference

Europe PubMed Central

30 August 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Carlo Bruno Giorda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Elisa Nada

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Barbara Tartaglino

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

8 February 2014

1 reference

Europe PubMed Central

30 August 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

46

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

406-419

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24510630%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

https://scigraph.springernature.com/pub.10.1007/s12020-014-0179-0

0 references

One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of diabetes mellitus and chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liraglutide-induced acute kidney injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide and sitagliptin are not associated with increased risk of acute renal failure: a retrospective claims analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24-week randomized placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of linagliptin in persons with type 2 diabetes inadequately controlled by a combination of metformin and sulphonylurea: a 24-week randomized study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of renal or hepatic impairment on the pharmacokinetics of saxagliptin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of 6-month sitagliptin treatment on glucose and lipid metabolism, blood pressure, body weight and renal function in type 2 diabetic patients: a chart-based analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide-associated ischemic renal failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin therapies in the management of patients with type 2 diabetes mellitus and renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saxagliptin improves glycaemic control and is well tolerated in patients with type 2 diabetes mellitus and renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: rates of diagnosis and antihyperglycemic medication dose adjustment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hyperglycemia in patients with chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of lixisenatide once-daily morning or evening injections in type 2 diabetes inadequately controlled on metformin (GetGoal-M).

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative tolerability profiles of oral antidiabetic agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Severe hypoglycemia in type I diabetic patients with impaired kidney function

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of liver diseases on the development of type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mild renal impairment and the efficacy and safety of liraglutide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of renal impairment on the pharmacokinetics of exenatide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Saxagliptin overview: special focus on safety and adverse effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of renal insufficiency on the pharmacokinetics of sitagliptin, a dipeptidyl peptidase-4 inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin-based therapy in chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinedione-induced edema

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of linagliptin in subjects with hepatic impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute tubulointerstitial nephritis following treatment with exenatide

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of alogliptin benzoate in hemodialysis patients with diabetes: a 2-year study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the Renal Insufficiency And Cardiovascular Events (RIACE) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/24510630

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38186638&oldid=2115025728"